
Sign up to save your podcasts
Or
In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about upadacitinib, a new treatment for giant-cell arteritis; growing evidence linking oral health to a higher risk of neurologic conditions; and why a trial of a new meningitis B vaccine drew a mixed response.
4.7
1919 ratings
In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about upadacitinib, a new treatment for giant-cell arteritis; growing evidence linking oral health to a higher risk of neurologic conditions; and why a trial of a new meningitis B vaccine drew a mixed response.
290 Listeners
322 Listeners
49 Listeners
874 Listeners
504 Listeners
13 Listeners
87 Listeners
24 Listeners
516 Listeners
131 Listeners
360 Listeners
183 Listeners
367 Listeners
5 Listeners
79 Listeners